Open-label phase Ib/II study of cetuximab (CET) plus LY3214996 with or without abemaciclib in patients (pts) with anti-EGFR-refractory metastatic colorectal cancer (mCRC). Survival of patients (pts) ...
In a pragmatic cluster non-randomized trial, Alexandra Kulinkina and colleagues investigate the effectiveness of a clinical decision support algorithm for guiding antibiotic prescribing in pediatric ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果